EN

Introduction

INCREASING HEALTH AWARENESS AND CHANGING LIFESTYLES HAVE LED TO A SURGE IN DEMAND FOR DIETARY SUPPLEMENTS. THIS DEMAND HAS FURTHER INCREASED DURING THE COVID-19 PANDEMIC, WITH A STRONG GROWTH FORECAST FOR THE MARKET VOLUME IN EUROPE IN THE NEXT TEN YEARS.

In recent years, notable transactions and innovations have characterized the supplement market in Germany. The number of start-ups in the sector has been at a high level, as they were able to quickly gain significant attention and market share through targeted marketing, for example through social media.

For Germany, we identified more than 400 relevant companies in the sector. From these, we have summarized what we consider to be the 40 most attractive in a ranking. To accomplish this task, a comprehensive review of all 400 companies was conducted, assessing them based on five key factors deemed relevant to our evaluation criteria: revenue, revenue growth, employee growth, web traffic, and diversity of distribution channels served. In all areas, a higher number correlated with a more favorable ranking.

In order to be included in our ranking, companies had to possess a unique characteristic that sets them apart from their peers. This could be anything from an extraordinary story or an emerging trend, to a unique market approach or growth pattern. Our Fabulous 40 list consists only of companies that have this unique quality. This means that even smaller companies have the potential to make it to the top of our Fab40 list. It is worth noting that all companies on our list are considered to be among the top 10% of companies in their sector.

Capitalmind Investec has acquired a strong expertise in the Healthcare sector by accompanying large groups, entrepreneurs, and mid-caps in their sales processes, acquisitions, and financings. Together with Investec as a significant majority shareholder, Capitalmind Investec has a global reaching network of M&A professionals.

Related Insights